Specifically, CRP gene methylation and polymorphisms in IL-6 (rs1800795) and interleukin-1 beta (IL-1β) (rs16944) have been identified as genetic risk loci associated with increased vulnerability to MDD [11,12,13]. This evidence concerns the gene CRP and major depressive disorder.